# Survodutide liver-activity study record updated

> ClinicalTrials.gov lists an active, not recruiting Survodutide study sponsored by Boehringer Ingelheim.

- Evidence object: `story:survodutide-liver-activity-study-updated:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-22
- Source checked: 2026-07-22
- Published by PeptideScanner: 2026-07-22
- Story landing page: https://peptidescanner.com/stories/survodutide-liver-activity-study-updated/
- JSON record: https://peptidescanner.com/evidence/v1/objects/survodutide-liver-activity-study-updated-v1.json
- Content SHA-256: `a8c9f7aa58e36ba2dc8907f665a1ad30562fa951386b62ff9cbd527a849d40b3`

## Claims and source pins

### Headline

Survodutide liver-activity study record updated ([`ctg-nct05202353-v50`](#source-ctg-nct05202353-v50))

### Summary

ClinicalTrials.gov lists an active, not recruiting Survodutide study sponsored by Boehringer Ingelheim. ([`ctg-nct05202353-v50`](#source-ctg-nct05202353-v50))

### Paragraph 1

ClinicalTrials.gov lists the NCT05202353 record under Boehringer Ingelheim. Its overall recruitment status was shown as active, not recruiting when PeptideScanner reviewed the record. ([`ctg-nct05202353-v50`](#source-ctg-nct05202353-v50))

### Paragraph 2

The registry shows 2026-07-22 as its latest posted update date. This update reports the registry record and does not establish safety, effectiveness, or a trial outcome. ([`ctg-nct05202353-v50`](#source-ctg-nct05202353-v50))

## Sources

<a id="source-ctg-nct05202353-v50"></a>
- **BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver · record history version 50 · last update posted 2026-07-22** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05202353?a=50&tab=history) (`ctg-nct05202353-v50`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Survodutide liver-activity study record updated." Version 1, published 2026-07-22. https://peptidescanner.com/evidence/v1/objects/survodutide-liver-activity-study-updated-v1.json SHA-256: a8c9f7aa58e36ba2dc8907f665a1ad30562fa951386b62ff9cbd527a849d40b3.